Aims & Objectives: Effective screening of donors blood as per WHO guidelines and to assess the sero prevalence of HIV, HBsAg, HCV, Syphilis and Malaria among population in a locality in southern part of India based on the data of screened donor blood bags. Material & Methods: During the period from 2012 to Aug 2018, a total number of 17,635 samples from the donated blood bags from a dedicated blood bank in southern part of India are screened for sero infections as per WHO guidelines using Elisa reader and RPR kit. The emphasis is on seroconversion when the tests result positive. The conclusive data is also compared with similar data in other parts of India studied by other eminent authors. Results & Discussion: It is observed that 297 samples are positive for HBsAg (1.68 %), 68 samples are positive for HIV (0.38 % ), and 59 samples are positive for HCV (0.33 %). Syphilis and Malaria reported not much significant as per Chi-square value. The data on comparision with other similar data showed similar trend except in the large sample study of 2,20,432 where syphilis reported high prevalence.
Introduction
Safe blood is a universal right. Blood transfusion has been a routine process in almost all hospitals worldwide. It is fairly acceptable by the public. It is thoroughly screened for seropositive infections like hepatitis B & C, HIV, Syphillis, Malaria commonly and rarely for TORCH infections in some centers. Measuring www.jmscr.igmpublication.org Impact Factor (SJIF): 6.379 Index Copernicus Value: 79.54 ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: https://dx.doi.org/10.18535/jmscr/v6i11.90 their severity, WHO recommended pretransfusion blood tests for HIV, HBV, HCV and syphilis as mandatory as blood transfusion carries the risk of TTI 20 (Transfusiontransmissible infections ). With each unit of blood transfused to the patient there is 1 % chance of TTI to transmit thereby causing significant health risk & economic burden to the person and the society.
Indian Scenario
The present trend in blood transfusion in India indicates an increase in TTI. India carries a burden of 50 -65 millions of HBV carriers and about 3 million HIV cases. Hence TTI can cause grave consequences if not contained soon. In India the overall sero prevalence is 4.1 %. India as a population of more than 1.3 billion with 5 -7 million HIV +ve cases, 43 million HBV +ve cases and 15 million HCV +ve persons. A very large study of 2, 20, 482 , automated protein micro array based tests have good antigen-antibody sensitivity. Antimicrobial agents given to recipients routinely can minimise transfusion malaria burden to a great extent. Seroconversion Seroconversion is defined as the appearance of specific anti HIV/HBV/HCV anti bodies in serum in 8 weeks after exposure. HIV is a single stranded RNA retrovirus. It is spread primarily by sexual exposure and also by blood, needle prics, vertical transmission from mother to child. Primary infection of HIV is symptomatic in 70 -80% of cases, occurs in 2-4 weeks after exposure. 75 % of transmission of HIV is heterosexual, 5 -10 % of new HIV are in children and more than 90 % of them are affected during pregnancy. Mother and child vertical transmission is 25 -44 % in developing countries. HBV is hepadna DNA virus of 4 -20 weeks incubation period, spread by blood saliva, sexual, syringes and vertical. Vaccine is available for HBV not for HIV and HCV. HCV is a flavivirus-RNA spreads by blood and saliva and not sexual nor vertical. Among health care workers in developing countries 40% of HIV infection is due to reused syringes & needles. With the help of nucleic acid based assays the risk of TTi's can be minimised by diagnosing the infection early and accurately even with minimal viral load which is achieved greatly by USA & EU. WHO recommended the use of latest generation of Elisa and rapid diagnostic genetic assays. The sero active blood bags have to be discarded as per WHO guidelines. Safe blood is a universal right is WHO's slogan. With HAART (Highly active anti retro viral therapy) regimen 80 % of patients have undetectable viral load (VL ) of < 50 copies per ml at 4 -6 months of treatment from the high VL of >1,00,000 copies per ml. Nevirapine & Efavirenz drugs are of immense value in controlling HIV viral replication. Entecavir & Telbivudine achieve HBV -DNA negativity in 90% of patients at one year of treatment of HBV. Graphs shown below clearly indicate the seroconversion of HBV and the carrier state and the next graph depicts seroconversion of HIV which are helpful in planning the drug treatment and resistance. Nucleic acid based assays of latest generation based on molecular biology of HIV, HBsAg, HCV are of great value in detecting even the lowest viremia even during window/latent phase of seroconversion. As such genetic based gadgets are used in the west the TTi prevalence rate is the lowest in the world. Only snag with such gadgets is they are not cost effective for developing countries with population explosion. The molecular structure of Hepatitis 'B' virus which is useful in targeting the drug action. HBV mutation and the natural course of Hepatitis 'B' disease with different phases of seroconversion like tolerance, clearance, latency and mutation which are significant in planning the time of performing the screening and diagnostic test to minimise TTi. Whereas Graph 1 gives a telltale picture of the amplitude of titre of different HBV antibodies which are of immense value in controlling the disease and minimising the spread of it. Graph 2 about the biological behaviour of HIV gives an idea about the seroconversion that takes place during the first few weeks of the total progression of the disease from 4 weeks to 3 years. The full blown picture of AIDS disease develops at the other end of the time scale of HIV. During the course the CD 4 titre falls after initial rise with the viral load (VL) increasing with advancing time. Untreated HIV cases can progress to AIDS in 25 -35 % of patients. 2012  2013  2014  2015  2016  2017  Aug-18  VOLUNTARY  1320  770  701  1357  1523  2061  1721  REPLACEMENT  575  648  560  960  1883  2673  883  TOTAL  1895  1418  1261  2317  3406  4734  2604   Table -3  Table - genomix molecular diagnostics is preferred to detect even the lowest grade parasitaemia. Rapid immune-chromo graphic technique detects HRP2 antigen of pl. Falciparium and pLDH antigen of other pl. Species. Several other infections having blood affinity and their transmissible nature like CMV, EBV, etc., has to be kept in mind. Special diagnostic aids have to be devised and developed to detect them. Thorough knowledge of seroconversion is of great value in screening and detecting the hidden load of TTi. The mutant nature of HBV is alarming and may not be detectable even by all advances in diagnostic serology. Dreier's 21 principles 2004 apply to detecting occult HBV or in window period donors who lack detectable HBsAg but positive for anti HBC and HBV DNA can be screened and are of great value in minimising the sero prevalent burden in the community. The mutant strains of HBV poses a grave problem and so the burden of HBV is still significant in the community despite advances in the field of immunology and molecular biology. HBV-DNA can be measured by PCR (polymerase chain reaction). Viral loads are use only in excess of 10 5 copies per ml in the presence of active viral replication, important in identifying patients with pre-core mutants. Specific HBV genotypes of A & B which cause more aggressive disease can be identified using PCR and plan treatment with interferons. HbeAg reflects active replication 5 -10 % HBV only develop chronic infection and 90 % may clear the virus. Yet 90 % of mother to child transmission results in chronic infection. Hence the focus must be on this particular age and sex population.
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